The present invention relates in general to the field of mobile structure assembly, and more particularly, to connecting a mobile cleanroom to another structure.
Without limiting the scope of the invention, its background is described in connection with cleanroom construction and use.
U.S. Pat. No. 6,634,149 B2, issued to Cates, et al teaches the configuration and assembly of components used to make up a wall system that is useful for cleanrooms. Specifically a connector block for joining perpendicularly oriented studs, and a corner stud and deflection track for connecting the top track of a wall panel to a conventional ceiling grid.
U.S. Pat. No. 5,713,791 A, issued to Long, et al., teaches a modular cleanroom conduit and the method for using it when transporting products between two cleanroom environments when traveling through a less clean environment between the cleanrooms. The conduit can be adapted and modified for various distances between two cleanrooms. Each modular section has perforated floors and filters for filtering incoming gas being circulated, and exhausting out gas and contaminates.
U.S. Pat. No. 4,667,579 A, issued to Daw, et al., teaches an industrial cleanroom structure having a plenum enclosure assembly on top of the cleanroom enclosure assembly. The plenum assembly has a top, bottom, and side covers that are sealed to prevent contamination, and a filter system through which air enters the cleanroom enclosure. The cleanroom enclosure includes fabricated wall studs attached to the plenum support structure.
U.S. Pat. No. 5,125,203 A, issued to Daw, et al., teaches a connector system to provide airtight sealing between a ceiling structure and a wall structure suitable for use in a cleanroom enclosure. The connector system includes an elongate channel member which is attached to the ceiling structure such that it forms a continuous airtight seal. An elongate cap member which is received within the elongate channel member is attached to the wall structure to form the top edge of the wall structure. Elastomeric seal members are placed between the cap member and the channel member to create an airtight seal.
In one embodiment, the present invention is a connector unit for connecting two or more structures wherein at least one of the two or more structures being connected is a mobile structure validatable for pharmaceutical manufacturing or patient care. The connection is made by the movement of the mobile structure against the other structure and the connector unit includes an alignment system that guides the mobile structure to precisely dock the two or more structures together, a seal or seal system to create an air tight seal between two or more structures, or one or more structures and an environment, and a fixation system to affix the two or more structures to prevent unintentional movements of the two or more structures, or breakage of the seal or seal system. The connector unit can be used to connect one, two, or more previously validated pharmaceutical manufacturing or patient care units. The connection between the two or more structures can be disconnected, separated, and then reattached. In another embodiment, the connector unit connects two or more structures wherein at least one of the structures includes at least one of cleanrooms, isolation cubicles, containment cubicles, pods, modules, units, buildings, corridors, hallways, mobile structures, and access structures. In another aspect, a volume of a seal between the two or more structures is equal to or greater than a volume of a groove on an opposite surface. In another aspect, the seal surrounds an opening between the two or more structures to provide a hermetic seal.
In one aspect, the alignment system of the connector unit allows two or more structures to be pushed against each other and aligned in the same movement. The alignment system is important to allow a firm sealing between the two or more structures, and to avoid any damage to the sealing. The seal or seal system of the connector unit between the structures shall be reversible, not allow any air leaks, and must be able to stay intact for a prolonged period of time. The seal or seal system between the two or more structures, or one or more structures and the environment, can include at least one of induction sealing, cap sealing, adhesive sealant, bodok seal, Bridgman seal, compression seal fitting, diaphragm seal, ferrofluidic seal, a gasket, flange gasket, o-ring, o-ring boss seal, glass-ceramic-to-metal seals, piston ring, hose coupling, hermetic seal, hydrostatic seal, hydrodynamic seal, labyrinth seal, face seal, plug, radial shaft seal, siphon trap, split mechanical seal, wiper seal, dry gas seal, and exitex seal. In yet another aspect, the fixation system which keeps the structures together and avoid unintentional movements can include at least one of clamps, spring loads, bolts, magnetic coupling, bayonet coupling, or locks. In another aspect, a volume of a seal between the two or more structures is equal to or greater than a volume of a groove on an opposite surface. In another aspect, the seal surrounds an opening between the two or more structures to provide a hermetic seal.
The present invention also includes a method for connecting two or more structures with a connector unit wherein at least one of the two or more structures being connected is a mobile structure validatable for pharmaceutical manufacturing or patient care, the method comprising aligning the two or more structures to precisely dock the two or more structures together, sealing the two or more structures, or one or more structures and an environment air tight with a seal or a sealing system, and affixing the two or more structures together solidly to prevent unintentional movements of the two or more structures, or breakage of the seal or seal system. In another aspect, a volume of a seal between the two or more structures is equal to or greater than a volume of a groove on an opposite surface. In another aspect, the seal surrounds an opening between the two or more structures to provide a hermetic seal.
For a more complete understanding of the features and advantages of the present invention, reference is now made to the detailed description of the invention along with the accompanying figures and in which:
While the making and using of various embodiments of the present invention are discussed in detail below, it should be appreciated that the present invention provides many applicable inventive concepts that can be embodied in a wide variety of specific contexts. The specific embodiments discussed herein are merely illustrative of specific ways to make and use the invention and do not limit the scope of the invention.
To facilitate the understanding of this invention, a number of terms are defined below. Terms defined herein have meanings as commonly understood by a person of ordinary skill in the areas relevant to the present invention. Terms such as “a”, “an” and “the” are not intended to refer to only a singular entity, but include the general class of which a specific example may be used for illustration. The terminology herein is used to describe specific embodiments of the invention, but their usage does not delimit the invention, except as outlined in the claims.
The present invention is a connector unit for connecting two or more structures wherein at least one of the two or more structures being connected is a mobile structure validatable for pharmaceutical manufacturing or patient care.
The present invention can be used with a modular pharmaceutical facility for the production of, e.g., vaccines and includes all the necessary quality control, quality assurance, and lot release functions. The end product can be made within the same or an adjacent module vaccine filled in bulk vials, suitable for distribution, and compliant with all FDA current Good Manufacturing Practices (cGMP) guidelines. The following terms are used interchangeably “modular unit”, “structure”, “unit” or “module” to describe a unitary structure that includes at least one portion that is a sealable, working area or cleanroom in which one or more functions or processes are conducted that require a controlled working environment and a mechanical service room or area (which may be closed or open) and that support the clean room and provides redundant services to the cleanroom, e.g., air-handling, electrical, water, waste water, waste disposal, chiller and/or heated water, gas, control units and sensors, security. These services will generally be connected to a source of the service that uses universal connectors, which are those commonly used as fittings in industry (e.g., 110 or 220 volt connections, ½-1 inch liquid or gas connections, wired or wireless connections to an intra, extra or internet and the like).
As used herein, the terms “validation” and “pre-validation” are intended to encompass all documented processes or acts undertaken to demonstrate that a procedure, a process or an activity will consistently yield an expected result or outcome. Validation often includes qualification of equipment and systems. Validation is a key required component of Good Manufacturing Practices (GMP) and other regulatory requirements. For example, in the pharmaceutical industry, validation of a facility and the process within it is done prior to obtaining regulatory approval for the commercial manufacture and sale of the pharmaceutical product. Validation activities in the pharmaceutical industry may also include trial runs (pre-validation) before performing the actual validation to set validation limits, critical manufacturing controls, alert limits, etc. and to assess the potential outcome of the actual validation run. Validations routinely performed are cleaning validation, process validation, analytical method validation, computer system validation, qualifying systems and equipment including: design qualification (DQ), component qualification (CQ), installation qualification (IQ), operational qualification (OQ), and process qualification (PQ).
The skilled artisan will recognize that though the connector units, structures, facilities or units described in the instant invention are validatable, they may not be validated or required to be validated for certain uses and applications, particularly for non-human use or manufacture of products for non-human consumption (for e.g. veterinary applications, agriculture applications, pesticide manufacture, etc.).
The connector unit of the present invention can be used to form a suite or be part of multiple-modular unit facility, can include specific enclosed spaces for the manufacture, fermentation, growth (e.g., in a bioreactor) of the composition requiring an FDA approved, GMP or cGMP facility that includes, e.g., lights, controlled GMP areas consistent with USDA, CDC, FDA or regulations for foreign equivalents, including clean room conditions, purification, chromatography, bulk or individual vial filling, that can be arranged within, e.g., a standard factory or facility with a clearance sufficiently high to accommodate the units within. In one example, the modular units can be placed within a building shell that includes standard electrical connections, water, wastewater, air handling to which the units are connected. The present invention requires no pre-assembly or re-assembly of the multiple units as each can function independently and can be used for multiple purposes.
For example, a complete manufacturing facility can be built, within hours to days, from pre-assembled, pre-approved modular units that include all the equipment necessary for the desired function(s) for that unit within a manufacturing plant using the connector units of the present invention. These flexible-by-design GMP modular units allow for the design of production facilities for the rapid deployment and re-deployment of units based on the design needs. For example, one modular unit may include a self-contained bioreactor, the necessary liquid handling devices, refrigerators, tissue culture hoods and microbiology testing equipment, basic laboratory equipment (pipettors, sterile pipette tips, growth media, petri dishes, incubators and other general lab supplies), that has been tested and prevalidated to be compliant with the cGMPs or other regulatory body compliance requirements or in compliance with applicable codes, statutes, ordinances, regulations or equivalents. A modular unit for protein isolation, adjacent to but completely independent from the bioreactor unit, can be positioned and in communication with the bioreactor unit such that the materials manufactured in the bioreactor are rapidly and easily transferred to the protein isolation unit that has, pre-approved and validated protein separation units, e.g., centrifuges, liquid chromatography columns, spectrophotometers, polyacrylamide gel electrophoresis (PAGE) units and bulk packaging units. Next, the bulk protein may be transferred to a packaging unit that includes all the equipment necessary to fill individual doses of the protein, small molecule or other agent that is being manufactured.
By connecting the individual modules, the present invention provides for the rapid exchange and continuous manufacture of product in case that one part of the manufacturing process must be changed or revalidated (e.g., in the case of the manufacture of a different biological or the detection of contamination) without the need to re-certify the entire facility. The addition of more modular units, connected by the connector unit(s) of the present invention, also allows for very rapid scale-up that can be customized for short periods of time. For example, a plant can receive the addition of modular units for scaling-up for a short period of time, the manufacture and isolation of a vaccine for a short period of time and the redeployment of those units elsewhere upon completion of the production run. In fact, the present invention can be used in existing manufacturing facilities for short-term expansion of manufacturing capacity without the need for revalidation of the new manufacturing capacity or the expensive, long-term installation of an additional production line that will only be used for a short period of time.
The connector units of the present invention can be used to connect modular units to stand-alone facilities and/or module units, which may be placed within and/or outside an existing structure. One example of such a structure is an empty facility or building. One such building could be of standard, pre-cast concrete construction, flat slab with smooth floors, concrete tilt wall, double T precast ceiling and having steel or other walls. In one non-limiting example, the walls can be epoxy coated for improved cleanability). Within the building, the modular units provide the dedicated wet laboratory, growth, bioprocess and purification units necessary for manufacture. These units are simply lifted into position (e.g., pushed on air bearings, casters, pallets), connected to a power source and, if necessary, a water and/or a wastewater supply.
The present invention allows the designer to have the ability to connect one functioning modular unit to one or more additional functioning modules without disrupting the function or compliance of the original modular unit(s). Furthermore, the designer also has the ability to disconnect one functioning module from one or more additional functioning modules without disrupting the function or compliance of the original modular unit(s).
The connector units taught herein can integrate into modular units to improve energy efficiency by connecting into an efficient energy recovery system that allows for energy recapture at a rate much higher than can be expected with existing methods throughout the connector unit(s) and the modular unit(s). The intake and exhaust of the redundant HVAC systems of the connector and modular unit(s) can be connected to the central HVAC of the building thereby enhancing the energy efficiency of both units. For example, the modular units of the present invention can be placed inside of a second environment (a building with ambient temperature or less humidity), which having the modular unit interact dynamically with that second environment. In this manner of operation, the modular unit can use ambient air that does not need to be treated by a large and expensive external air handling unit.
Another vast improvement over existing designs is the ability of the modular units to service multiple clients with a single cluster of modular units in a single contiguous manner through the connector units. For example, a biotechnology research park or similar entrepreneurial facility could host various different companies, each having their own production facility or modular unit. One distinct advantage of using the modular units is that each completely selfcontained modular unit can contain an individual hazardous waste, spills, etc., without affecting any other structures (within a process flow or affecting an adjacent production facility, e.g., when a facility has various manufacturing lines or different companies).
When the modular unit needs to be connected to a source of water, the incoming water could be purified in an adjacent modular unit that could service various different production lines or the module itself could include a water purification unit. The modular unit of the present invention has the advantage that the redundant air handling units, electrical panels and even the water filtration units can be in the portion of the modular unit that is adjacent the clean room and can be serviced without service personnel having to enter the clean room area. When handling wastewater, the modular unit can include sump pumps to eliminate waste. Furthermore, the bag in/bag out filters connected to the air-handling units can also be changed without the need to enter the cleanroom area. These separate externally accessible portions of the modular units allow for maintenance and maintenance personnel to service the unit without the need to gown-up and enter the clean room area.
Duplicate processes and equipment for air handling, exhaust, etc., with automatic fault tolerance/failover allows the user, e.g., from an external panel or via the internet, to switch-over from a first system to a second system if sensors within the modular unit sense a problem with a component in the first system or as part of regular maintenance.
Another feature of the connector units of the present invention is the ability to use utility and other connection devices (e.g., plugs and fittings) that are well-known to maintenance personnel. For example, the modular units can use standard quick connectors for chilled water, electricity, etc. that allow the user to ‘hot swap’ the modular units externally. One advantage of the present invention is that it can take advantage of existing building infrastructure, e.g., mechanical equipment such as boilers, clean steam generator and compressors that can easily be connected to the units. The building's existing maintenance facilities and personnel can provide maintenance and service to the units and environmental service compliance from outside the clean room space via the mechanical are of the unit that is separate from the clean room space.
The connector units of the present invention can be made from, for example, a welded aluminum frame, with an all aluminum wall structure of materials and coatings that are cleanable in the drug production environment and are compliant with the cGMP's as described by the USDA, CDC, FDA or equivalent regulatory agency. Stainless steel fixtures and surfaces may also be used when necessary, but could add more weight to the unit if a weight limit exists.
The connection of the connector unit, e.g., within the clean room portion of the modular unit or even the maintenance portion of the modular unit, can be controlled and monitored externally using standard network information systems and remote systems monitoring.
Moreover, modular or connector units can be outfitted with air bearings, so that the modular units can be moved easily to other areas to be reconfigured in near real time to support necessary processes and surge capabilities without disturbing ongoing operations.
Each connector unit can be preassembled with a final documentation package that can include: the design, structural, mechanical, and electrical drawings, system dossiers, installation qualification and operational qualification plan and executed documents, maintenance logs, and pro-forma quality assurance documents including basic standard operating procedures for connecting into modular units and/or fixed facilities. These may be provided in hard copy, or provided via a display panel within the modular unit or externally (including within the maintenance bay) that is electronic and can include the necessary passcode/password protection.
Space pressure can be monitored, e.g., the pressure in the connector units and/or modular unit(s) to which they are connected. If the pressure drops to 0.0″ water column (WC) or below, an alarm can be sent to the BAS. When an alarm is sent to the BAS, the system can call pre-programmed emergency telephone numbers and/or communication electronically via text or email.
Additional Points that can be monitored in the connector unit include, e.g., a static pressure blowout sensor in communication with the air handling units (AHU's) For example, the BAS can determine if there is a belt failure in either of the AHU's or EF's by using, e.g., an amp sensor that monitors the change in amp draw on the motor. Another sensor can be a pitot tube in the supply air duct and exhaust air duct that monitors static pressure connected to the BAS. Also, gravity dampers, automatic dampers and damper end switches and the controls can also be connected to and monitored by the BAS.
One embodiment is a single layer, rounded rectangular seal 60 that is placed between surfaces 44a and 46a. The seal can positioned opposite of the seal 60 shown by placing the seal on surface 46a instead of 44a (not depicted). Alternatively, the seal 60 can enter a groove 61 in surface 46a, with the volume of the seal 60 being equal to or greater than the volume of the groove 61 in surface 46a. The groove 61 and seals 60 can be positioned on either surface 44a or 46a, can be alternated, and can also surround the openings between cleanroom 16 and corridor 20.
Another embodiment is a double layer, thinner rounded seal 62 on surface 44b, which fits into grooves 63 on surface 46b or can contact surface 46b directly. Seal 62 and grooves 63 can be positioned vice versa with the seal on surface 46b instead, and the grooves 63 on surface 44b. The groove 63 and seals 62 can be positioned on either surface 44b or 46b, can be alternated, and can also surround the openings between cleanroom 16 and corridor 20.
Another embodiment is a trapezoidal shaped seal 64 between surfaces 44c and 46c wherein the seal would be thicker against one surface (or vice versa). The seal 64 can be positioned on surface 46c instead of 44c. Likewise, the seal 64 shown herein is not limited to a specific surface, but can be on surface 46c with the thicker lining against surface 44c. As with the embodiment described above, the seal 64 can enter the grooves 65 or directly contact the surface 46b (or vice versa). The groove 65 and seals 64 can be positioned on either surface 44c or 46c, can be alternated, and can also surround the openings between cleanroom 16 and corridor 20.
The fourth embodiment shows a single layer wider rounded seal 66 between surface 44d and 46d. Again, The seal 66 can be on surface 46d instead of 44d. As with the embodiment described above, the seal 68 can enter the grooves 67 or directly contact the surface 46b (or vice versa). The groove 67 and seals 66 can be positioned on either surface 44d or 46d, can be alternated, and can also surround the openings between cleanroom 16 and corridor 20. The seal or seal system of the connector unit between the structures shall be reversible allowing the two structures to be undocked and separated when necessary. The seal system needs to not allow any air leaks, and must be able to stay intact for a prolonged period of time. There are multiple other designs available for the seal or seal system between the two or more structures, or one or more structures and the environment. The seal system designs for the connector unit can include at least one of induction sealing, cap sealing, adhesive sealant, bodok seal, Bridgman seal, compression seal fitting, diaphragm seal, ferrofluidic seal, a gasket, flange gasket, o-ring, o-ring boss seal, glass-ceramic-to-metal seals, piston ring, hose coupling, hermetic seal, hydrostatic seal, hydrodynamic seal, labyrinth seal, face seal, plug, radial shaft seal, siphon trap, split mechanical seal, wiper seal, dry gas seal, or exitex seal.
It is contemplated that any embodiment discussed in this specification can be implemented with respect to any method, kit, reagent, or composition of the invention, and vice versa. Furthermore, compositions of the invention can be used to achieve methods of the invention.
It will be understood that particular embodiments described herein are shown by way of illustration and not as limitations of the invention. The principal features of this invention can be employed in various embodiments without departing from the scope of the invention. Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, numerous equivalents to the specific procedures described herein. Such equivalents are considered to be within the scope of this invention and are covered by the claims.
All publications and patent applications mentioned in the specification are indicative of the level of skill of those skilled in the art to which this invention pertains. All publications and patent applications are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
The use of the word “a” or “an” when used in conjunction with the term “comprising” in the claims and/or the specification may mean “one,” but it is also consistent with the meaning of “one or more,” “at least one,” and “one or more than one.” The use of the term “or” in the claims is used to mean “and/or” unless explicitly indicated to refer to alternatives only or the alternatives are mutually exclusive, although the disclosure supports a definition that refers to only alternatives and “and/or.” Throughout this application, the term “about” is used to indicate that a value includes the inherent variation of error for the device, the method being employed to determine the value, or the variation that exists among the study subjects.
As used in this specification and claim(s), the words “comprising” (and any form of comprising, such as “comprise” and “comprises”), “having” (and any form of having, such as “have” and “has”), “including” (and any form of including, such as “includes” and “include”) or “containing” (and any form of containing, such as “contains” and “contain”) are inclusive or open-ended and do not exclude additional, unrecited elements or method steps.
The term “or combinations thereof” as used herein refers to all permutations and combinations of the listed items preceding the term. For example, “A, B, C, or combinations thereof” is intended to include at least one of: A, B, C, AB, AC, BC, or ABC, and if order is important in a particular context, also BA, CA, CB, CBA, BCA, ACB, BAC, or CAB. Continuing with this example, expressly included are combinations that contain repeats of one or more item or term, such as BB, AAA, AB, BBC, AAABCCCC, CBBAAA, CABABB, and so forth. The skilled artisan will understand that typically there is no limit on the number of items or terms in any combination, unless otherwise apparent from the context. In certain embodiments, the present invention may also include methods and compositions in which the transition phrase “consisting essentially of” or “consisting of” may also be used.
As used herein, words of approximation such as, without limitation, “about”, “substantial” or “substantially” refers to a condition that when so modified is understood to not necessarily be absolute or perfect but would be considered close enough to those of ordinary skill in the art to warrant designating the condition as being present. The extent to which the description may vary will depend on how great a change can be instituted and still have one of ordinary skilled in the art recognize the modified feature as still having the required characteristics and capabilities of the unmodified feature. In general, but subject to the preceding discussion, a numerical value herein that is modified by a word of approximation such as “about” may vary from the stated value by at least ±1, 2, 3, 4, 5, 6, 7, 10, 12 or 15%.
All of the compositions and/or methods disclosed and claimed herein can be made and executed without undue experimentation in light of the present disclosure. While the compositions and methods of this invention have been described in terms of preferred embodiments, it will be apparent to those of skill in the art that variations may be applied to the compositions and/or methods and in the steps or in the sequence of steps of the method described herein without departing from the concept, spirit and scope of the invention. All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope and concept of the invention as defined by the appended claims.
U.S. Pat. No. 4,667,579
U.S. Pat. No. 5,125,203
U.S. Pat. No. 5,713,791
U.S. Pat. No. 6,634,149
This application is a non-provisional application of U.S. Provisional Patent Application Ser. No. 61/890,516 filed on Oct. 14, 2013 and entitled “Unit for Connecting Modular Mobile Rooms” the entire contents of which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
1965451 | Brown | Jul 1934 | A |
1967511 | Meyer | Jul 1934 | A |
2156859 | Lowe | May 1939 | A |
2247893 | Sieber | Jul 1941 | A |
2480144 | Laycock | Aug 1949 | A |
2793067 | Couse | May 1957 | A |
2795014 | Kelly | Jun 1957 | A |
2904850 | Couse | Sep 1959 | A |
2965412 | Henderson | Dec 1960 | A |
3023463 | Bigelow, Jr. | Mar 1962 | A |
3103709 | Bolt | Sep 1963 | A |
3162320 | Hitch | Dec 1964 | A |
3378963 | Obata | Apr 1968 | A |
3392497 | Cushman | Jul 1968 | A |
3495865 | Hill | Feb 1970 | A |
3566554 | Schaffer et al. | Mar 1971 | A |
3690077 | Dalgliesh, Jr. | Sep 1972 | A |
3727753 | Starr | Apr 1973 | A |
3742932 | Greenspan | Jul 1973 | A |
3766844 | Donnelly et al. | Oct 1973 | A |
3775919 | Fulton | Dec 1973 | A |
3807789 | Turquin | Apr 1974 | A |
3832811 | Briel, Jr. | Sep 1974 | A |
3838880 | Lefebvre | Oct 1974 | A |
3984950 | Hildebrand | Oct 1976 | A |
3992828 | Ohe | Nov 1976 | A |
4255912 | Kovacs | Mar 1981 | A |
4409889 | Burleson | Oct 1983 | A |
4599829 | DiMartino, Sr. | Jul 1986 | A |
4633626 | Freeman | Jan 1987 | A |
4667579 | Daw | May 1987 | A |
4667580 | Wetzel | May 1987 | A |
4694736 | Yamagata | Sep 1987 | A |
4707953 | Anderson | Nov 1987 | A |
4739597 | Voegeli | Apr 1988 | A |
4779514 | Prigmore | Oct 1988 | A |
4850268 | Saito et al. | Jul 1989 | A |
4852310 | Henley | Aug 1989 | A |
4915435 | Levine | Apr 1990 | A |
4923352 | Tamura et al. | May 1990 | A |
4970834 | Polson | Nov 1990 | A |
5060426 | Jantzen | Oct 1991 | A |
5125203 | Daw | Jun 1992 | A |
5152814 | Nelson | Oct 1992 | A |
5191742 | Romig | Mar 1993 | A |
5195922 | Genco | Mar 1993 | A |
5233803 | Bockmiller | Aug 1993 | A |
5319904 | Pascoe | Jun 1994 | A |
5344365 | Scott et al. | Sep 1994 | A |
5353557 | Lerner et al. | Oct 1994 | A |
5365013 | Aulson | Nov 1994 | A |
5412913 | Daniels | May 1995 | A |
5491934 | Bigelow et al. | Feb 1996 | A |
5511594 | Brennan et al. | Apr 1996 | A |
5562539 | Hashimoto et al. | Oct 1996 | A |
5656491 | Cassani et al. | Aug 1997 | A |
5706846 | Sutton | Jan 1998 | A |
5713791 | Long | Feb 1998 | A |
5735639 | Payne et al. | Apr 1998 | A |
5755479 | Lavin et al. | May 1998 | A |
5768829 | Thompson | Jun 1998 | A |
5795356 | Leveen | Aug 1998 | A |
5806248 | Kim | Sep 1998 | A |
5864991 | Burns | Feb 1999 | A |
5904005 | Dyer | May 1999 | A |
5941846 | Duffy | Aug 1999 | A |
5964065 | Migurski | Oct 1999 | A |
6155747 | Payne | Dec 2000 | A |
6179358 | Hirayama et al. | Jan 2001 | B1 |
6250022 | Paz | Jun 2001 | B1 |
6299008 | Payne | Oct 2001 | B1 |
6394523 | Yoo et al. | May 2002 | B1 |
6512384 | Lagowski et al. | Jan 2003 | B1 |
6568147 | Sumner, Sr. | May 2003 | B1 |
6625937 | Parker | Sep 2003 | B1 |
6634149 | Cates et al. | Oct 2003 | B2 |
6849100 | Lim et al. | Feb 2005 | B2 |
6960236 | Tamura et al. | Nov 2005 | B1 |
6969102 | Orischak et al. | Nov 2005 | B2 |
6990715 | Liu et al. | Jan 2006 | B2 |
7160717 | Everett | Jan 2007 | B2 |
7162833 | Faris | Jan 2007 | B2 |
7222246 | Pomaranski et al. | May 2007 | B2 |
7269925 | Lam | Sep 2007 | B2 |
7272733 | Pomaranski et al. | Sep 2007 | B2 |
7272833 | Pomaranski et al. | Sep 2007 | B2 |
7326355 | Graetz | Feb 2008 | B2 |
7472513 | Bula | Jan 2009 | B2 |
7511960 | Hillis et al. | Mar 2009 | B2 |
7527664 | Jackson | May 2009 | B2 |
7644970 | Chui et al. | Jan 2010 | B2 |
7712270 | Guevremont | May 2010 | B2 |
7724518 | Carlson et al. | May 2010 | B1 |
7779586 | Stewart et al. | Aug 2010 | B2 |
7794001 | Blackwell | Sep 2010 | B2 |
7827738 | Abrams | Nov 2010 | B2 |
7861102 | Ranganathan et al. | Dec 2010 | B1 |
7934124 | Bechtolsheim et al. | Apr 2011 | B2 |
7946644 | Foster | May 2011 | B1 |
7985382 | Henry et al. | Jul 2011 | B1 |
8042562 | McDaniel, Jr. | Oct 2011 | B1 |
8061080 | Loebl et al. | Nov 2011 | B2 |
8065560 | Patil | Nov 2011 | B1 |
8082699 | Kychelhahn | Dec 2011 | B1 |
8097451 | Gaalswyk | Jan 2012 | B2 |
8147301 | Ghattas | Apr 2012 | B2 |
8239340 | Hanson | Aug 2012 | B2 |
8371912 | Ozeki | Feb 2013 | B2 |
8479038 | Patil | Jul 2013 | B1 |
8584349 | Scannon et al. | Nov 2013 | B2 |
8707630 | Jhaveri et al. | Apr 2014 | B1 |
8776445 | Jhaveri et al. | Jul 2014 | B1 |
8776446 | Jhaveri | Jul 2014 | B1 |
20020174888 | Brown | Nov 2002 | A1 |
20030024172 | Lyons | Feb 2003 | A1 |
20030138344 | Mielnik et al. | Jul 2003 | A1 |
20030140555 | Saether | Jul 2003 | A1 |
20040194484 | Zou et al. | Oct 2004 | A1 |
20040201239 | Pellegrin, Jr. | Oct 2004 | A1 |
20040255449 | Koren et al. | Dec 2004 | A1 |
20050091916 | Faris | May 2005 | A1 |
20050193643 | Pettus | Sep 2005 | A1 |
20050226794 | Hodge et al. | Oct 2005 | A1 |
20050279035 | Donovan | Dec 2005 | A1 |
20060107635 | Homan et al. | May 2006 | A1 |
20060150534 | Window | Jul 2006 | A1 |
20060185262 | Abler | Aug 2006 | A1 |
20070089854 | Jaisinghani | Apr 2007 | A1 |
20070130844 | Arts et al. | Jun 2007 | A1 |
20070132262 | Sun et al. | Jun 2007 | A1 |
20070167126 | Ghattas | Jul 2007 | A1 |
20070170740 | Di Franco | Jul 2007 | A1 |
20070228692 | Kern | Oct 2007 | A1 |
20070251145 | Brusatore | Nov 2007 | A1 |
20080047224 | Lam | Feb 2008 | A1 |
20080256878 | Berns | Oct 2008 | A1 |
20080261220 | Cracauer et al. | Oct 2008 | A1 |
20080302004 | Lin | Dec 2008 | A1 |
20090122533 | Brukilacchio | May 2009 | A1 |
20090199470 | Capen et al. | Aug 2009 | A1 |
20090217600 | De Azambuja | Sep 2009 | A1 |
20090249708 | Zschornack et al. | Oct 2009 | A1 |
20090305626 | Hope | Dec 2009 | A1 |
20100024330 | Sodaro | Feb 2010 | A1 |
20100024352 | Pope | Feb 2010 | A1 |
20100031564 | Loebl et al. | Feb 2010 | A1 |
20100112926 | Ozeki | May 2010 | A1 |
20110053486 | Holtz et al. | Mar 2011 | A1 |
20110185646 | Kovel | Aug 2011 | A1 |
20110232543 | Burroughs | Sep 2011 | A1 |
20110258837 | Scannon et al. | Oct 2011 | A1 |
20110265396 | Heather | Nov 2011 | A1 |
20120077429 | Wernimont et al. | Mar 2012 | A1 |
20120099035 | Burgess | Apr 2012 | A1 |
20120181869 | Chapel et al. | Jul 2012 | A1 |
20130019913 | Zadok | Jan 2013 | A1 |
20130109291 | Holtz | May 2013 | A1 |
20140179216 | Walters | Jun 2014 | A1 |
20160010883 | Jornitz | Jan 2016 | A1 |
Number | Date | Country |
---|---|---|
201281413 | Jul 2009 | CN |
0400575 | Dec 1990 | EP |
940292 | Sep 1999 | EP |
2098111 | Sep 2009 | EP |
61101733 | May 1986 | JP |
63-135736 | Aug 1988 | JP |
05-106887 | Apr 1993 | JP |
06-174279 | Jun 1994 | JP |
06183511 | Jul 1994 | JP |
10077711 | Mar 1998 | JP |
2000142211 | May 2000 | JP |
2001141274 | May 2001 | JP |
2002-129666 | May 2002 | JP |
2002221464 | Aug 2002 | JP |
2002-332753 | Nov 2002 | JP |
2004033498 | Feb 2004 | JP |
2004233021 | Aug 2004 | JP |
2007107779 | Apr 2007 | JP |
2007107830 | Apr 2007 | JP |
08-304989 | Dec 2008 | JP |
2009002634 | Jan 2009 | JP |
2011-185593 | Sep 2011 | JP |
100675682 | Dec 2006 | KR |
200912219 | Mar 2009 | TW |
19961026329 | Aug 1996 | WO |
0002618 | Jan 2000 | WO |
03088886 | Oct 2003 | WO |
03095765 | Nov 2003 | WO |
04005170 | Jan 2004 | WO |
2004106669 | Dec 2004 | WO |
2007067656 | Jun 2007 | WO |
08018671 | Feb 2008 | WO |
2011022325 | Feb 2011 | WO |
2013132086 | Sep 2013 | WO |
Entry |
---|
Astra-Zeneca Pharmaceutical Building, Vanguard Modular Building Systems Brochure, Dec. 9, 2004, 2 pages. |
Cleanroom Solutions, Starrco Brochure, 4 pages. Starrco Company, Inc. |
HDW Series, “Hardwall Cleanroom”, Abtech, Inc., p. 8. |
Muth, Laboratory Design, “Modular Construction: Pros and Cons for the Lab Building,” R&D Magazine, Jun. 17, 2009, 5 pages. |
Pharmadule Press Release, “Pharmadule Doubles Production Capacity and Acquires Patent for Modular Biotech Plants,” Sep. 27, 2002, 1 page, http://www.pharmadule.com/pharmadule-doubles-production-capacity-an . . . . |
International Search Report, PCT/US2014/060505, Nov. 26, 2014. |
Extended European Search Report dated Sep. 30, 2016, 8 pp. |
International Search Report and Written Opinion PCT/US2015/040023 dated Jul. 10, 2015. |
Moldenhauer, J., “Understanding Cleanroom Classifications,” Mar. 24, 2014, http://www.cemag.us/article/2014/03/understanding-cleanroom-classifications. |
Extended European Search Report for EP 15819080.1 dated Mar. 22, 2018, 11 pp. |
Number | Date | Country | |
---|---|---|---|
20150101264 A1 | Apr 2015 | US |
Number | Date | Country | |
---|---|---|---|
61890516 | Oct 2013 | US |